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receptor) are monomers in the cell membrane. Ligand
binding induces dimerization of these receptors re-
sulting in autophosphorylation of their cytoplasmic do-
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mains (Schlessinger, 1988; Lemmon and Schlessinger,New York University Medical Center
1994; Jiang and Hunter, 1999). Members of the IR family550 First Avenue
are disulfide linked dimers of two polypeptide chainsNew York, New York 10016
forming an a2b2 heterodimer (Van-Obberghen, 1994). In-
sulin binding to the extracellular domain of the IR in-
duces a rearrangement in the quaternary heterotetrameric
structure that leads to increased autophosphorylationA large group of genes in all eukaryotes encode for
of the cytoplasmic domain. As the active forms of insulinproteins that function as membrane spanning cell sur-
receptor and monomeric RTKs are both dimeric, theface receptors. Membrane receptors can be classified
signaling mechanisms of the two types of receptor areinto distinct families based upon the ligands they recog-
likely to be very similar (Hubbard et al., 1998).nize, the biological responses they induce and, more
Activation by Dimerizationrecently, according to their primary structures. A great
Although all RTKs are activated by dimerization, differ-variety of ligands bind to and regulate the activity of cell
ent ligands employ different strategies for inducing thesurface receptors, including small organic molecules,
active dimeric state. Structural studies of growth hor-lipids, carbohydrates, peptides, and proteins. One large
mone (GH) in complex with GH receptor (GHR) and eryth-family of cell surface receptors is endowed with intrinsic
ropoietin (EPO) in complex with EPO receptor (EPOR)protein tyrosine kinase activity. These receptor tyrosine
show that these cytokines are bivalent, and one ligandkinases (RTKs) catalyze transfer of the g phosphate of
binds simultaneously to two receptor molecules to formATP to hydroxyl groups of tyrosines on target proteins
a 1:2 (ligand:receptor) complex (Kossiakoff and De Vos,(Hunter, 1998). RTKs play an important role in the control
1998; Jiang and Hunter, 1999). Receptor dimerization isof most fundamental cellular processes including the
further stabilized by additional receptor:receptor inter-cell cycle, cell migration, cell metabolism and survival,
actions.as well as cell proliferation and differentiation. All recep-
Several growth factors are homodimers (e.g., VEGF,tor tyrosine kinases contain an extracellular ligand bind-
PDGF) providing the simplest mechanism for ligand-ing domain that is usually glycosylated. The ligand bind-
induced receptor dimerization. The VEGF receptorsing domain is connected to the cytoplasmic domain by
(VEGFR) contain seven immunoglobulin (Ig)-like domainsa single transmembrane helix. The cytoplasmic domain
in their extracellular domain, of which only Ig-domains 2contains a conserved protein tyrosine kinase (PTK) core
and 3 are required for ligand binding. The crystal struc-and additional regulatory sequences that are subjected
ture of VEGF in complex with Ig-like domain 2 of theto autophosphorylation and phosphorylation by heterol-
flt-1 VEGFR provides a view of ligand-induced receptorogous protein kinases (Hunter, 1998; Hubbard et al.,
dimerization (Wiesmann et al., 1997). The structure1998). Lymphokines such as erythropoietin and inter-
shows that one receptor molecule binds at each of theferon also mediate their responses by tyrosine phos-
two junctions between VEGF protomers to yield a com-phorylation. However, rather than containing an intrinsic
plex that is close to 2-fold symmetric, and contains twoprotein tyrosine kinase activity, the relatively short cyto-
VEGF protomers plus the two Ig-like domains.plasmic domains of these receptors interact through
The fibroblast growth factor (FGF) family consists of
noncovalent interactions with members of the Jak family
at least 21 related growth factors (Maski and Ornitz,
of nonreceptor tyrosine kinases (Darnell et al., 1994; Ihle,
1998). FGFs are unable to activate FGF receptors (FGFR)
1995). Apart from the lack of covalent linkage to a kinase, without cooperation of the accessory molecule heparin
the mechanism of activation of these binary receptors sulfate proteoglycan (HSPG) (Yayon et al., 1991). The
largely resembles that of receptor tyrosine kinases crystal structures of FGF in complex with the ligand bind-
(Lemmon and Schlessinger, 1994; Heldin, 1995; Jiang ing domain of FGFR (consisting of Ig-like domains-2
and Hunter, 1999). The purpose of this review is to de- [D2] and -3 [D3]) provide a molecular view of FGFR
scribe general concepts underlying the mechanism of dimerization (Plotnikov et al., 1999; Schlessinger et al.,
action of RTKs and the signaling pathways that they 2000) and activation and illustrate the determinants that
regulate, while attempting to shed light on the question govern FGF:FGFR specificity (Plotnikov et al., 2000).
of how specificity is defined by the action of RTKs, and Each structure shows a 2:2 FGF:FGFR complex, in which
how a specific biological response can be generated by FGF interacts extensively with D2, D3, and with the linker
the diverse array of signaling pathways activated by all that connects these two domains within one receptor
RTKs. (the primary binding site). The dimer is stabilized by a
secondary binding site involving interactions between
Paradigms for Receptor Activation FGF and D2 of the second receptor in the complex, as
With the exception of the insulin receptor (IR) family well as by receptor:receptor interactions. In contrast
of RTKs, all known RTKs (e.g., EGF receptor, PDGF to the disulfide linked VEGF homodimer, the two FGF
molecules in the 2:2 FGF:FGFR complex do not make
any contact. Indeed, interactions between FGF and* E-mail: schlej01@popmail.med.nyu.edu
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FGFR alone are not sufficient for stabilizing FGFR dimers autophosphorylation and stimulation of PTK activity (ac-
tive dimer). Ligand binding to the extracellular domainat the cell surface under normal physiological condi-
tions. Heparin or heparan sulfate proteoglycans are es- stabilizes the formation of active dimers and conse-
quently PTK stimulation. We propose that active dimerssential for stable dimerization of FGF:FGFR complexes
(Spivak-Kroizman et al., 1994). It has been shown that exist even in the absence of ligand binding since auto-
phosphorylation of RTKs can be enhanced by inhibitorsheparin binds to a positively charged canyon formed by
a cluster of exposed Lys and Arg residues that extends of protein tyrosine phosphatases or by receptor overex-
pression even in the absence of ligand binding.across the D2 domains of the two receptors in the dimer
and the adjoining bound FGF molecules (Schlessinger The Role of Receptor Hetero-Oligomerization
The EGFR family consists of four RTKs, EGFR (ErbB1),et al., 2000). The full-length FGFR contains an additional
Ig-like domain (D1) and a stretch of acidic residues or ErbB2, ErbB3, and ErbB4. While EGFR has numerous
ligands (e.g., EGF, TGFa, HB-EGF), a ligand for ErbB2“acid box” in the linker between D1 and D2. Neither D1
nor the acid box is required for FGF binding to the FGFR. has not been identified. The ligands for ErbB3 and
ErbB4, the two other members of this RTK family, areIn fact, deletion of D1 and the acid box enhances binding
of the receptor to FGF and heparin (Wang et al., 1995). the various isoforms of the neuregulins (NRG). It was
demonstrated over a decade ago that EGF-inducedRecent studies we have carried out lead us to propose
that D1 and the acid box in full-length FGFR have an stimulation of EGFR leads to activation of ErbB2 by
transduction through hetero-oligomerization (King et al.,autoinhibitory function (Plotnikov et al., 1999). It is
thought that the acid box can bind intramolecularly to 1988; Stern and Kamps, 1988; Wada et al., 1990). Subse-
quently, numerous studies have demonstrated thatthe heparin binding site in D2, competing with heparin
for binding to this site. Similarly, D1 may interact intra- stimulation with EGF or NRG induces a combinatorial
hetero-oligomerization of different pairs of members ofmolecularly with the ligand binding domain in D2 and
D3 and thus interfere with FGF binding to FGFR. This the EGFR family (Carraway and Cantley, 1994; Lemmon
and Schlessinger, 1994; Olayioye et al., 2000). In theautoinhibition would prevent accidental FGF-indepen-
dent activation of FGFR by HSPGs that are abundant absence of a specific ligand for ErbB2, it was proposed
that this RTK may function as a heterodimeric partnerin the extracellular matrix and on cell surfaces. Ac-
cording to this view, the extracellular domain of FGFR of the other members of the family, and could provide
an additional platform for recruitment of intracellularhas an autoregulatory function in addition to its roles in
ligand recognition and receptor dimerization. A similar signaling pathways in response to EGF or NRG stimula-
tion. Moreover, since the sequence of the ErbB3 cata-mechanism of autoinhibition may apply for other RTKs
that contain multiple Ig-like domains in their extracellu- lytic domain suggests that this receptor does not have
PTK activity, it is thought that ErbB3 may function as alar domains (e.g., PDGFR, VEGFR). As only 2 out of the
5 Ig-like domains of PDGFR, and just 2 of the 7 Ig-like platform to expand the repertoire of intracellular signal-
ing proteins recruited following its trans-phosphoryla-domains of VEGFR are essential for ligand binding, it is
possible that the extra Ig-like domains not involved in tion by other members of the EGFR family (Carraway
and Cantley, 1994).ligand binding could play an autoregulatory role in these
receptors. In the absence of structural information about EGFR,
it is difficult to present a clear molecular picture concern-The control of FGFR stimulation by two ligands, FGF
and heparin, may provide a mechanism for localized ing the mechanism of receptor dimerization and hetero-
oligomerization. Biophysical studies have suggestedactivation of FGFR and vectorial stimulation of cell prolif-
eration or differentiation. The biosynthesis of HSPGs in that EGF is bivalent toward EGFR and shown that EGF
can drive dimerization of the EGFR extracellular domainrestricted areas of the extracellular matrix of different
tissues may provide a scaffold to which cells expressing ending with a stoichiometry of 2:2 EGF:EGFR (Lemmon
et al., 1997; Ferguson et al., 2000). It has been proposedFGFR will migrate, and on which these cells will survive,
proliferate, or undergo differentiation when supplied that the bivalency of EGF or NRG is the driving force
for heterodimerization of ErbB2 with other members ofwith a specific FGF molecule. Indeed, it was demon-
strated that FGF8 and FGFR1 are essential for cell migra- the EGFR family (Tzahar et al., 1997). However, presently
there is no evidence for binding of EGF or NRG to thetion and mesodermal patterning during gastrulation (Ya-
maguchi et al., 1994; Sun et al., 1999). extracellular domain of ErbB2 (Feurguson et al., 2000).
The exact mechanism of ligand-dependent dimerizationRecent biochemical and structural studies and earlier
experiments using monoclonal anti-receptor antibodies of members of the EGFR family must await the determi-
nation of the three-dimensional structures of these com-have demonstrated that only certain forms of receptor
dimers with unique configurations of the extracellular plexes. An alternative mechanism is that two receptor
homodimers form a heterodimer. Figure 2 shows a po-and cytoplasmic domains of both RTKs and cytokine
receptors lead to trans-autophosphorylation and PTK tential mechanism for EGF-induced heterotetramer for-
mation between EGFR and ErbB2. According to thisstimulation (Lemmon and Schlessinger, 1994; Jiang and
Hunter, 1999). Figure 1 depicts a model for how mono- scenario EGF-induced homodimers form a tetrameric
complex with unoccupied homodimers of ErbB2 by re-meric RTKs (Figure 1A) (e.g., EGFR, VEGFR) or disulfide
bridged heterotetrameric RTKs (Figure 1B) (e.g., IR, ceptor:receptor interactions. The interactions between
the two homodimers within the context of a heterotet-IGF1R) are activated. It is thought that receptor mono-
mers are in equilibrium with receptor dimers. A limited ramer could serve to stabilize the formation of one di-
mer indirectly by growth factor binding. For example,population of receptor dimers exist with quaternary
structures of their extracellular and cytoplasmic do- binding of two monomeric ErbB2 proteins to an EGF-
induced homodimer of EGFR may cause homodimeriza-mains in configurations that are compatible with trans-
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Figure 1. Ligand Binding Stabilizes the For-
mation of Activated Dimers
(A) Inactive receptor monomers (green) are
in equilibrium with inactive (green) or active
(blue) receptor dimers. The active receptor
dimers exist in a conformation compatible
with trans-autophosphorylation and stimula-
tion of PTK activity (blue). Ligand binding sta-
bilizes active dimer formation and hence PTK
activation.
(B) Inactive disulfide bridged insulin-receptor
(IR) dimers (green) are in equilibrium with ac-
tive dimers (blue). Insulin binding stabilizes
the active dimeric state leading to PTK acti-
vation.
tion of the ErbB2 molecules followed by their trans- on the receptor itself and on cellular proteins involved
in signal transmission.autophosphorylation and consequent activation (Ho-
negger et al., 1990; Qian et al., 1994; Gamett et al., 1997;
Huang et al., 1998). The mechanism of heterotetramer Mechanism of Activation of Signaling Proteins
formation between ErbB3 and ErbB4 may be different, In addition to its central role in the control of protein
since both receptors bind NRG and may undergo NRG- tyrosine kinase activity, tyrosine autophosphorylation of
dependent homodimerization (Figure 2). In this case, RTKs is crucial for recruitment and activation of a variety
ErbB3 homodimers may interact with NRG-induced ho- of signaling proteins. Most tyrosine autophosphoryla-
modimers of ErbB4, which in turn will phosphorylate tion sites are located in noncatalytic regions of the re-
the cytoplasmic domains of ErbB3 proteins by trans- ceptor molecule. These sites function as binding sites
phosphorylation. In other words, homodimers of ErbB3 for SH2 (Src homology 2) or PTB (phosphotyrosine bind-
may in fact be preferable substrates of ErbB4 within the ing) domains of a variety of signaling proteins. SH2 do-
context of a heterotetrameric complex. main–mediated binding of signaling proteins to tyrosine
Structural studies of the catalytic core of several autophosphorylation sites provides a mechanism for as-
RTKs, together with biochemical and kinetic studies of sembly and recruitment of signaling complexes by acti-
receptor phosphorylation and activation have provided vated receptor tyrosine kinases. According to this view,
insights into the mechanism by which RTK dimerization every RTK should be considered not only as a receptor
activates enzymatic activity (Hubbard et al., 1994; Mo- with tyrosine kinase activity but also as a platform for the
hammadi et al., 1996; Hubbard, 1997). The emerging recognition and recruitment of a specific complement of
picture is that receptor oligomerization increases the signaling proteins (Pawson and Schlessinger, 1993).
local concentration of the PTK, leading to more efficient Modular Domains of Signaling Proteins
transphosphorylation of tyrosine residues in the activa- Signaling proteins containing SH2 and PTB domains are
tion loop of the catalytic domain (Hubbard et al., 1998). modular in nature (Kuriyan and Cowburn, 1997; Pawson
Structural studies have shown that, upon tyrosine phos- and Scott, 1997; Margolis, 1999). Many of these proteins
phorylation, the activation loop adopts an “open” con- contain intrinsic enzymatic activities and protein mod-
figuration that permits access to ATP and substrates, ules that bring about interactions with other proteins,
with phospholipids, or with nucleic acids. Protein mod-and enables phosphotransfer from MgATP to tyrosines
Cell
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Figure 2. Activation of Members of the EGFR
Family by Hetero-Tetramer Formation
(A) EGF binding induces the formation of acti-
vated EGFR (blue) homodimers (step 1). Bind-
ing of two monomeric ErbB2 (green) proteins
(step 2) to an activated EGFR dimer (blue)
induces homodimerization of ErbB2 (cyan)
molecules followed by autophosphorylation
and ErbB2 activation (step 3).
(B) A general scheme for activation of mem-
bers of the EGFR family by hetero-tetramer
formation (EGFR 5 B1, ErbB2 5 B2, ErbB3 5
B3, and ErbB4 5 B4).
(1) Hetero-tetramer formation between an
EGF-induced EGFR homodimer (B1) and two
ErbB2 (B2) molecules. Two ErbB2 molecules
dimerize by binding to an activated EGFR di-
mer (as in panel A). Arrows mark autophos-
phorylation between two EGFRs (B1) or be-
tween two ErbB2 molecules (B2). Broken
arrows mark potential transphosphorylation
between B1 and B2 or between B2 and B1.
(2) Hetero-tetramer formation between an
EGF-induced EGFR homodimer (B1) and an
NRG-induced ErbB3 homodimer (B3). Arrows
mark autophosphorylation of B1 and trans-
phosphorylation of B3 by B1.
(3) Hetero-tetramer formation between an
NRG-induced ErbB3 homodimer (B3) and an
NRG-induced ErbB4 homodimer (B4). Arrows
mark autophosphorylation of B4 and trans-
phosphorylation of B3 by B4.
(4) Hetero-tetramer formation between an
EGF-induced EGFR homodimer (B1) and an
NRG-induced ErbB4 homodimer (B4). Arrows
mark autophosphorylation of B1 and B4.
Broken arrows mark potential transphos-
phorylation between B1 and B4 or between
B4 and B1.
ules involved in cellular signaling processes range in to their soluble head groups, the physiological ligands
of the majority of PH domains remain to be identified.size from 50 to 120 amino acids. Figure 3 depicts several
protein modules that have been shown to be involved However, the weak and nonspecific binding of most PH
domains to phosphoinositides may be compensated forin cellular signaling downstream of RTKs and other cell
surface receptors. SH2 domains bind specifically to dis- by the oligomeric nature of certain PH domain–contain-
ing proteins leading to strong membrane associationtinct amino acid sequences defined by 1 to 6 residues
C-terminal to the pTyr moiety (Songyang et al., 1993), (Lemmon and Ferguson, 2000). Finally, FYVE domains
comprise another family of small protein modules thatwhile PTB domains bind to pTyr within context of spe-
cific sequences 3 to 5 residues to its N terminus (Mar- specifically recognize PtdIns-3-P (Fruman et al., 1999),
and PDZ domains belong to another large family of inde-golis, 1999). Certain PTB domains bind to nonphosphor-
ylated peptide sequences, while still others recognize pendent protein modules that bind specifically to hy-
drophobic residues at the C termini of their target pro-both phosphotyrosine-containing and nonphosphory-
lated sequences equally well (Margolis, 1999). SH3 do- teins (Gomperts, 1996).
A large family of SH2 domain–containing proteins pos-mains bind specifically to the proline-rich sequence mo-
tif PXXP, while WW domains bind preferentially to sess intrinsic enzymatic activities such as PTK activity
(Src kinases), protein tyrosine phosphatase (PTP) activ-another proline-rich motif PXPX (Kuriyan and Cowburn,
1997). Pleckstrin homology (PH) domains comprise a ity (Shp2), phospholipase C activity (PLCg), or Ras-GAP
activity among other activities. Another family of pro-large family of more than a hundred domains. While
certain PH domains bind specifically to PtdIns(4,5)P2, teins contains only SH2 or SH3 domains. These adaptor
proteins (e.g., Grb2, Nck, Crk, Shc) utilize their SH2 andanother subset of PH domains binds preferentially to
the products of agonist-induced phosphoinositide-3- SH3 domains to mediate interactions that link different
proteins involved in signal transduction. For example,kinases (PI-3 kinase) (Ferguson et al., 1995; Lemmon et
al., 1995, 1996; Czech, 2000). As only a small subset of the adaptor protein Grb2 links a variety of surface recep-
tors to the Ras/MAP kinase signaling cascade. Grb2PH domains bind specifically to phosphoinositides or
Review
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Figure 3. Protein Modules and Docking Pro-
teins that Participate in Signaling via Recep-
tor Tyrosine Kinases
(A) Protein modules implicated in the control
of intracellular signaling pathways. Tyrosine
phosphorylated, activated RTKs form a com-
plex with SH2 and PTB domains of signaling
proteins. SH2 domains bind to pTyr sites in
activated receptors while PTB domains bind
to tyrosine phosphorylated and nonphos-
phorylated regions in RTKs. PH domains bind
to different phosphoinositides leading to
membrane association. SH3 and WW do-
mains bind to proline-rich sequences in target
proteins. PDZ domains bind to hydrophobic
residues at the C termini of target proteins.
FYVE domains bind specifically to PdtIns(3)P.
While adaptor proteins such as Grb2 or Nck
contain only SH2 and SH3 domains, other
signaling proteins contain additional enzy-
matic activities such as protein kinases
(Src,PKB), PTPase (Shp2) phospholipase C
(PLCg), Ras-GAP or Rho-GRF (Vav).
(B) Docking proteins that function as plat-
forms for recruitment of signaling proteins.
All docking proteins contain a membrane tar-
geting region in their N termini. FRS2 is tar-
geted to the membrane by myristoylation,
and LAT is targeted to the cell membrane
by a transmembrane domains (TM) and by
palmytoylation. Most docking proteins are
targeted to the cell membrane by their PH
domains. Docking proteins contain multiple
pTyr phosphorylation sites that function as
binding sites for SH2 domains of a variety of
signaling proteins.
interacts with activated RTKs via its SH2 domain and surface receptors. The PTB domains of IRS1 and IRS2,
for example, bind specifically to IR, IGF1-R or IL4-R.recruits the guanine nucleotide releasing factor Sos
close to its target protein Ras at the cell membrane The PTB domains of FRS2a and FRS2b on the other
hand, bind preferentially to FGFR or NGFR. It has been(Schlessinger, 1994; Pawson, 1995).
Docking Proteins shown that docking proteins function as platforms for
the recruitment of signaling proteins in response to re-Agonist-induced membrane recruitment of signaling
proteins stimulated by tyrosine phosphorylation is also ceptor stimulation. In fact, most of the signaling proteins
that are activated in response to insulin or FGF stimula-mediated by a family of docking proteins. Figure 3 de-
picts a schematic diagram of several docking proteins. tion are recruited via the IRS or FRS families of docking
proteins and not by their direct binding to IR or FGFR.All docking proteins contain in their N termini a mem-
brane targeting signal and in their C termini a large region It appears that the total amount of signaling proteins
that are recruited by a given activated RTK is the sumthat contains multiple binding sites for the SH2 domains
of signaling proteins (Sun et al., 1993; Kouhara et al., of the proteins recruited by the receptor directly, and
those recruited by docking proteins that are tyrosine1997). Some docking proteins are associated with the
cell membrane by a myristyl anchor (e.g., FRS2), while phosphorylated by the same receptor.
Paradigms for Activation of Effector Proteinsothers have their own transmembrane domain (e.g., LAT)
(Zhang et al., 1998a). However, most docking proteins Although many proteins serve as substrates of, and are
activated by, RTKs, there appear to be three differentcontain a PH domain at their N terminus. Docking pro-
teins such as Gab1 become associated with the cell general mechanisms for how signaling proteins are acti-
vated in response to RTK stimulation. Figure 4 summa-membrane by binding of its PH domain to PtdIns(3,4,5)P3
in response to agonist-induced stimulation of PI-3 ki- rizes three effector systems that exemplify these non–
mutually exclusive paradigms for activation of effectornase (Rodrigues et al., 2000). In addition to the mem-
brane targeting signal, most docking proteins contain proteins by RTKs.
Activation by Membrane Translocation. PDGF-inducedspecific domains such as PTB domains that are respon-
sible for complex formation with a particular set of cell activation of PI-3 kinase leads to generation of the sec-
Cell
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Figure 4. Paradigms for Activation of Signal-
ing Proteins in Response to RTK Activation
At least two separate molecular events are
required for RTK-induced activation of signal-
ing molecules. As many protein targets of
RTKs are located at the cell membrane, trans-
location to the cell membrane is essential for
activation of many effector proteins.
(A) Activation of PKB (also known as Akt) by
membrane translocation. PtdIns(3,4,5)P3 gen-
erated in response to growth factor stimulation
serves as a binding site for the PH domains
of PDK1 and PKB. Membrane translocation is
accompanied by release of an autoinhibition
leading to activation of PDK1 and PKB kinase
activities. Full activation of PKB requires phos-
phorylation by PDK1 (and also by PDK2?). Acti-
vated PKB phosphorylates a variety of target
proteins that prevent apoptotic death and
regulate various metabolic processes.
(B) Activation by a conformational change.
Binding of the SH2 domains of p85, the regu-
latory subunit of PI-3 kinase to pTyr sites on
activated receptors releases an autoinhibi-
tory constraint that stimulates the catalytic
domain (p110). PI-3 kinase catalyzes the
phosphorylation of the 39 positions of the ino-
sitol ring of PtdIns(4)P and PtdIns(4,5)P2 to
generate PtdIns(3,4)P2 and PtdIns(3,4,5)P3,
respectively.
(C) Activation by tyrosine phosphorylation.
Binding of the SH2 domains of PLCg to pTyr
sites in activated receptors facilitates tyro-
sine phosphorylation of PLCg as well as
membrane translocation; a process mediated
in part by binding of the PH domain to PI-3
kinase products. Tyrosine phosphorylation is
essential for PLCg activation leading to hy-
drolysis of PtdIns(4,5)P2 and the generation
of the two second messengers Ins(1,4,5)P3
and diacyglycosol.
ond messengers PtdIns(3,4)P2 and PtdIns(3,4,5)P3. The ity. However, it was recently reported that phosphoryla-
tion of Ser473 is mediated by PKB trans-autophosphory-generation of these second messengers plays a crucial
role in the activation of PDK1 and PKB (also known as lation (Toker and Newton, 2000a, 2000b [this issue of
Cell]).AKT), two highly conserved protein kinases that play
an important role in stimulation of cell survival, protein Activation by a Conformational Change. There is good
evidence that SH2 domain–mediated binding of certainsynthesis, and metabolic processes (Figure 4A). PDK1
has a PH domain at the C terminus of the protein through signaling proteins to phosphotyrosines on activated re-
ceptors induces a conformational change that releaseswhich it binds to PtdIns(3,4,5)P3 leading to membrane
translocation (Alessi et al., 1997; Anderson et al., 1998). an autoinhibition resulting in stimulation of enzymatic
activity. For example, the protein tyrosine kinase activityPKB, which is also recruited to the membrane via its
N-terminal PH domain binding to PI-3 kinase products of Src is activated when its SH2 domain binds to tyrosine
autophosphorylation sites on PDGFR (Thomas and(Franke et al., 1995; Frech et al., 1997), is phosphorylated
by PDK1 on Thr308 in its activation loop. It has been Brugge, 1997; Xu et al., 1999). Similarly, binding of p85,
the regulatory subunit of PI-3 kinase, to phosphotyro-proposed that an as yet unidentified protein kinase (hy-
pothetical PDK2) is responsible for PKB phosphorylation sines in the PDGFR or IRS1 causes conformational
changes in p85 that are transmitted to the catalytic sub-on Ser473 leading to complete stimulation of PKB activ-
Review
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unit p110 leading to enhancement of PI-3 kinase activity naling networks that are activated by cell surface recep-
tors (Figure 5). General principles that govern the(Figure 4B). In addition, by binding to tyrosine phosphor-
spatiotemporal information flow from the cell surface toylated PDGFR or IRS1, PI-3 kinase is translocated to
the nucleus, and the modes of communication betweenthe cell membrane where its substrate PtdIns(4,5)P2 is
the different signaling pathways are becoming unveiled.found.
The Ras/MAP Kinase Signaling CascadeActivation by Tyrosine Phosphorylation. It has been
All RTKs and many other cell surface receptors stimulateshown that tyrosine phosphorylation of certain target
the exchange of GTP for GDP on the small G proteinproteins is required for ligand stimulation of their enzy-
Ras. Both biochemical and genetic studies have demon-matic activity (Figure 4C). In response to EGF, PDGF,
strated that Ras is activated by the guanine nucleotideor FGF receptor activation, the SH2 domains of PLCg
exchange factor, Sos. The adaptor protein Grb2 playsbind to specific phosphotyrosines in the C-terminal tails
an important role in this process by forming a complexof these receptors. Binding of PLCg to the activated
with Sos via its SH3 domains. The Grb2/Sos complexreceptor facilitates its efficient tyrosine phosphorylation
is recruited to an activated RTK through binding of theby the RTK. PDGF-induced activation of phospholipase
Grb2 SH2 domain to specific pTyr sites of the receptor,C activity is abrogated in cells expressing PLCg mutated
thus translocating Sos to the plasma membrane wherein the tyrosine phosphorylation sites (Kim et al., 1991).
it is close to Ras and can stimulate exchange of GTPActivation of PLCg is also dependent upon agonist-
for GDP (Schlessinger, 1994; Pawson, 1995; Bar-Sagiinduced generation of PI-3 kinase products. Both tyrosine
and Hall, 2000 [this issue of Cell]). Membrane recruit-phosphorylation and membrane translocation of PLCg
ment of Sos can be also accomplished by binding ofthrough binding of its PH domain to PtdIns(3,4,5)P3 are
Grb2/Sos to Shc, another adaptor protein that forms aessential for complete activation of phospholipase-C
complex with many receptors through its PTB domainactivity leading to the generation of the two second
(Margolis, 1999). Alternatively, Grb2/Sos complexes canmessengers diacylglycerol and Ins(1,4,5)P3 (Falasca et
be recruited to the cell membrane by binding to mem-al., 1998).
brane-linked docking proteins such as IRS1 or FRS2aAs many of the targets of RTKs are membrane linked,
which become tyrosine phosphorylated in response tomembrane translocation of key signaling components
activation of certain RTKs (Sun et al., 1993; Kouhara etis critical in the process of signal transduction. At least
al., 1997). There is also evidence that the PH domaintwo molecular events must take place before agonist-
of Sos is essential for membrane translocation and forinduced activation of each of the effector proteins de-
complete activation of Ras. Once in the active GTP-scribed in Figure 4 can occur. PKB activation, for exam-
bound state, Ras interacts with several effector proteinsple, requires translocation to the plasma membrane and
such as Raf and PI-3 kinase to stimulate numerous in-phosphorylation by PDK1 on a key Thr residue. Further-
tracellular processes. Activated Raf stimulates MAP-more, it was proposed that translocation of PKB to the
kinase-kinase (MAPKK, MEK) by phosphorylating a keycell membrane is accompanied by release of an autoin-
Ser residue in the activation loop. MAPKK then phos-hibition suggesting that a conformational change in PKB
phorylates MAPK (ERK) on Thr and Tyr residues at themay also take place and be required for phosphorylation
activation-loop leading to its activation. Activated MAPKby PDK1 and for kinase activation (Figure 4A). PDGF-
phosphorylates a variety of cytoplasmic and membraneinduced activation of PI-3 kinase is mediated by a con-
linked substrates (e.g., EGFR, Sos). In addition, MAPKformational change in PI-3 kinase induced by p85 binding
is rapidly translocated into the nucleus where it phos-to pTyr sites on activated PDGFRs (Figure 4B). Stimulation
phorylates and activates transcription factors (Karin andof PLCg, on the other hand, is dependent on both tyro-
Hunter, 1995; Hunter, 2000). The signaling cassette com-sine phosphorylation and PI-3 kinase activation (Figure
posed of MAPKKK, MAPKK, and MAPK is highly con-4C). Membrane translocation is essential for PI-3 kinase
served in evolution and several MAPK cascades exist
and PLCg activation, as PtdIns(4,5)P2, the substrate of in yeast, in invertebrates and vertebrates (Waskiewicz
these two enzymes is located in the cell membrane.
and Cooper, 1995; Madhani and Fink, 1998; Garrington
and Johnson, 1999). These highly conserved signaling
Intracellular Signaling Pathways cascades play an important role in the control of meta-
The rapid progress in understanding intracellular signal- bolic processes, cell cycle, cell migration, and cell shape
ing pathways that took place during the 1990s was as well as in cell proliferation and differentiation (Davis,
largely due to the convergence of information generated 2000 [this issue of Cell]).
by multiple scientific disciplines. Similar proteins were Phosphoinositol Metabolism and Cell Signaling
repeatedly identified by applying totally different meth- Activation of RTKs leads to rapid stimulation of phos-
odologies. Key components of signaling pathways have phoinositol metabolism and generation of multiple sec-
been discovered in biochemical studies in which cellular ond messengers (Rameh and Cantley, 1999; Czech,
proteins were isolated, cloned, and analyzed. The inver- 2000). PLCg is rapidly recruited by an activated RTK
tebrate C. elegans and Drosophila homologs of the same through the binding of its SH2 domains to pTyr sites in
proteins have been found in genetic screens. Moreover, the receptor molecules. Upon activation PLCg hydro-
in many cases the same proteins have been identified lyzes its substrate PtdIns(4,5)P2 to form two second
as products of genes that are mutated in different human messengers, diacylglycerol and Ins(1,4,5)P3. By binding
diseases such as cancer, severe skeletal disorders, im- to specific intracellular receptors, Ins(1,4,5)P3 stimulates
munodeficiencies, and neurological diseases. A picture the release of Ca21 from intracellular stores. Ca21 then
is starting to emerge with regard to the different compo- binds to calmodulin, which in turn activates a family of
Ca21/calmodulin-dependent protein kinases. In addi-nents of several signal transduction pathways and sig-
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Figure 5. Signaling Pathways Activated by
RTKs
(A) Different signaling pathways are pre-
sented as distinct signaling cassettes (col-
ored boxes). In several cases the signaling
cassettes do not include all the known com-
ponents of a given pathway. Also shown, ex-
amples of stimulatory and inhibitory signals
for the different pathways. For example, in
addition to activation of the MAP kinase sig-
naling cascade, Ras activates PI-3 kinase and
Cdc42. Stimulation of PI-3 kinase leads to
activation of PDK1 and PKB, two kinases that
regulate various metabolic processes and
prevent apoptotic death. In addition, PI-3 ki-
nase activation stimulates generation of hy-
drogen peroxide which in turn oxidizes and
blocks the action of an inhibitory protein tyro-
sine phosphatase (PTP). The signaling cas-
settes presented in the figure regulate the
activity of multiple cytoplasmic targets. How-
ever, the Ras/MAP, STAT, JNK, and PI-3 ki-
nase signaling pathways also regulate the
activity of transcriptional factors by phos-
phorylation and by other mechanisms.
(B) Mechanisms for attenuation and termina-
tion of RTK activation. In several cases the
activity of RTKs can be negatively regulated
by ligand antagonists or by hetero-oligomer-
ization with naturally occurring dominant in-
terfering receptor variants. The PTK activity
of EGFR is attenuated by PKC-induced phos-
phorylation at the juxtamembrane region. De-
phosphorylation of key regulatory pTyr resi-
dues by protein tyrosine phosphatases (PTP)
may inhibit kinase activity or eliminate dock-
ing sites. An important mechanism for signal
termination is via receptor endocytosis and
degradation. The oncogenic protein Cbl
binds to pTyr sites in activated RTKs via its
SH2-like domain. The RING finger domain of
Cbl functions as a ubiquitin-ligase leading to
receptor ubiquitination and degradation by
the proteosome.
tion, both diacylglycerol and Ca21 activate members of ated through binding of their PH domains to agonist-
induced PI-3 kinase products leading to their activationthe PKC family of protein kinases. The second messen-
gers generated by PtdIns(4,5)P2 hydrolysis stimulate a and subsequent stimulation of a variety of cellular re-
sponses (Figure 4). One important response is stimula-variety of intracellular responses in addition to phos-
phorylation and activation of transcriptional factors tion of cell survival. It has been shown that PI-3 kinase-
dependent activation of PKB leads to phosphorylation(Karin and Hunter, 1995; Hunter, 2000).
The phospholipid kinase PI-3 kinase is activated by and inactivation of BAD. Phosphorylation of BAD pre-
vents apoptotic cell death by blocking its complex for-virtually all RTKs. One group of PI-3 kinases are hetero-
dimers composed of a regulatory subunit p85, which mation with the apoptotic protein Bcl-2 and Bcl-xl (Fig-
ure 4A) (Datta et al., 1999). Another mechanism forcontains two SH2 and one SH3 domain and a catalytic
subunit designated p110. Like other SH2 domain– inhibition of apoptosis is via PKB-induced phosphoryla-
tion of the transcription factor FKHR1 (Brunet et al.,containing proteins, PI-3 kinase forms a complex with
pTyr sites on activated receptors or with tyrosine 1999), which in turn suppresses proapoptotic gene ex-
pression. Insulin-induced activation of PDK1 leads tophosphorylated docking proteins such as IRS1 and
Gab1. Activated PI-3 kinase phosphorylates PtdIns(4)P phosphorylation and activation of S-6 kinase. Further-
more, glycogen synthase kinase-3 (GSK-3) and phos-and PtdIns(4,5)P2 to generate the second messengers
PtdIns(3,4)P2 and PtdIns(3,4,5)P3. PtdIns(3,4,5)P3 medi- phofruckokinase, two enzymes that are regulated in re-
sponse to insulin stimulation, are phosphorylated byates membrane translocation of a variety of signaling
proteins, such as the non–receptor protein tyrosine ki- PKB. PDK1 and PKB may play a role in the control of
protein synthesis, gluconeogenesis, and glycolysis innases Btk and Itk, the Ser/Thr kinases PDK1 and PKB,
the Arf exchange factor Grp1, the docking protein Gab1, response to insulin stimulation (Toker and Newton,
2000a).and PLCg1, among many others (Rameh and Cantley,
1999; Czech, 2000). Membrane translocation is medi- PI-3 kinase also plays an important role in growth
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factor–induced hydrogen peroxide generation. It has to EGFR, competes with Spitz for receptor binding, and
inhibits EGFR activity (Figure 5B). It has been proposedbeen recently shown that PDGF-induced H2O2 genera-
that the regulated expression of an EGFR agonist (Spitz),tion is dependent upon activation of PI-3 kinase and the
and EGFR antagonist (Argos) is essential for the controlsmall G protein Rac (Bae et al., 2000). Earlier studies
of various regulatory networks in which EGFR plays andemonstrated that activation of NADPH synthase, the
important role in Drosophila development (Casci andenzyme complex that catalyzes the production of hydro-
Freeman, 1999). No vertebrate homolog of Argos hasgen peroxide, is an effector of Rac. Interestingly, EGF-
been identified and the mechanism of its antagonisticinduced generation of H2O2 is essential for sustained
activity is not yet understood (Jin et al., 2000).tyrosine autophosphorylation and activation of EGFR
Another example of an RTK antagonist comes from(Bae et al., 1997). Hydrogen peroxide that is generated
the family of angiopoietins. Angiopoietins belong to ain response to EGF stimulation oxidizes and inactivates
family of multimeric proteins that regulate mammaliana protein tyrosine phosphatase (PTP) that dephosphory-
vascularization and angiogenesis. Angiopoietins bindlates activated EGFR (Lee et al., 1998; Bae et al., 2000).
specifically to and activate Tie2, an RTK expressed onRegulation of EGFR kinase activity is not the only role
the surface of endothelial cells that is implicated in theof hydrogen peroxide in response to growth factor stim-
control of vascularization and angiogenesis. Interest-ulation. There is good evidence that H2O2 plays an active
ingly, one group of angiopoietins inhibits the biologicalrole in the control of multiple cellular processes.
responses mediated by the Tie2 receptor (MaisonpierreThe activity of effector proteins that are dependent
et al., 1997). It is thought that the spatiotemporal expres-on PI-3 kinase activation can be negatively regulated
sion of the stimulatory and inhibitory angiopoietins isby PTEN and SHIP, two phosphoinositide-specific
critical for shaping and remodeling the vascular systemphosphatases that dephosphorylate the 39 and 59 posi-
during development. Moreover, the degree of receptortions of the inositol ring of phosphoinositides, respec-
oligomerization induced by the inhibitory or stimulatorytively (Bolland et al., 1998; Maehama and Dixon, 1998).
angiopoietins may determine biological outcome.PTEN is a tumor suppressor protein that is mutated in
Hetero-Oligomerization with Receptor Mutantsa variety of human cancers leading to aberrant stimula-
In addition to transcripts encoding for full-length RTKs,tion of cell survival pathway (Maehama and Dixon, 1998).
certain tissues express naturally occurring soluble orNuclear Translocation of STATs
membrane-linked receptor variants that are deficient inAll lymphokines induce gene transcription by activating
RTK activity. Expression of an inactive deletion mutantthe JAK/STAT signaling pathway (Darnell et al., 1994;
in the same cell may result in dominant negative inhibi-Ihle, 1995). The binding of lymphokines to their binary
tion of full-length receptor through generation of inactivereceptor complexes leads to the activation of JAK and
heterodimers or hetero-oligomers (Jaye et al., 1992). Itsubsequent tyrosine phosphorylation of STATs. This is
is thought that one biological role of mutant receptorfollowed by binding of the SH2 domain of STAT to pTyr
variants coexpressed in the same cell with full-lengthsites on homotypic or heterotypic STATs enabling for-
receptors is to provide a mechanism for attenuating ofmation of STAT homodimers or heterodimers. The di-
the signal generated by ligand stimulation of the full-meric STATs migrate to the nucleus to activate tran-
length receptor (Figure 5B).scription in a target DNA sequence designated the GAS
Inhibition of RTK Activityelement. In addition to their central role in signaling
Activation of protein kinase-C (PKC) by G protein–via lymphokine receptors, there is good evidence that
coupled receptors or by PDGF or phorbol-esters (PMA)STATs play a role in signaling via RTKs. PDGF, EGF, or
results in EGFR phosphorylation on multiple Ser andFGF stimulation leads to rapid tyrosine phosphorylation
Thr residues, including Thr654 in the juxtamembraneand migration of STATs to the nucleus and transcription
domain of EGFR. PKC-induced phosphorylation ofof target DNA genes. The transcriptional program initi-
EGFR results in an inhibition of its PTK activity and in
ated by STATs is an integral component of the genetic
strong inhibition of EGF binding to the extracellular li-
program induced by growth factor stimulation. More-
gand binding domain (Cochet et al., 1984; Davis and
over, there is good evidence that STAT3 plays a role in Czech, 1985). PKC-mediated phosphorylation of the jux-
PTK-induced oncogenic transformation, as constitu- tamembrane domain of EGFR thus appears to provide
tively dimeric forms of STAT3 promote tumor formation. a negative feedback mechanism for control of receptor
activity.
Mechanism of Signal Attenuation and Termination SOCS (suppressor of cytokine signaling) belongs to
The activity of RTKs must be tightly regulated and prop- a family of proteins that function as negative regulators
erly balanced in order to mediate their normal cellular for feedback inhibition in response to cytokine stimula-
tasks and their many physiological responses. Indeed, tion (Hilton et al., 1998). It has been shown that SOCS
aberrant expression or dysfunction of RTKs is responsi- proteins inhibit signaling in response to cytokine stimu-
ble for several diseases and developmental disorders. lation by direct binding to the PTK domain of JAK via
It is to be expected, therefore, that several mechanisms their SH2 domains. There is now evidence that insulin
exist for the attenuation and termination of RTK activity stimulation induces the expression of SOCS-3 and that
induced by stimulatory ligands. SOCS-3 binds directly to the IR suggesting that a similar
Antagonistic Ligands negative feedback mechanism may take place in signal-
In Drosophila, activation of the EGFR homolog by an ing via RTKs (Emmanuelli et al., 2000).
EGF-like factor (e.g., Spitz) leads to the expression of Inhibition by Tyrosine Phosphatases
a secreted EGF-like protein designated Argos. Genetic Protein tyrosine phosphatases (PTP) play an important
role in the control of RTK activity and the signaling path-and biochemical experiments suggest that Argos binds
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ways that they regulate. Virtually all RTKs can be acti- ing hyperosmotic conditions and ultraviolet radiation,
as well as by G protein–coupled receptors (Carpenter,vated, even in the absence of ligand binding, by treat-
ment of cells with PTP inhibitors. This experiment 1999). Agonists of several G protein–coupled receptors
(e.g., endothelin, lysophosphatidic acid, angiotensin,demonstrates that the activity of RTKs is continuously
being monitored and checked by inhibitory PTPs. The and thrombin) have been shown to stimulate the tyrosine
phosphorylation of EGFR or PDGFR. It has also beenprotein tyrosine kinase activity of most RTKs is positively
regulated by one or several phosphotyrosine sites in proposed that EGFR and PDGFR, as well as the nonre-
ceptor PTKs, Src and PYK2, are crucial for couplingthe activation loop. Protein tyrosine phosphatases that
dephosphorylate these regulatory p-Tyr residues will G protein–coupled receptors stimulation with the Ras/
MAP kinase signaling cascade (Luttrell et al., 1999;inhibit RTK activity and the biological responses medi-
ated by downstream effectors that depend on PTK activ- Hackel et al., 1999). However, it is not yet clear how
Gi- and Gq-dependent pathways activate these proteinity. It was recently demonstrated that targeted gene
disruption of PTP1B in mice leads to hyperphosphoryla- tyrosine kinases. Moreover, MAP kinase stimulation in-
duced by G protein–coupled receptors is normal in fibro-tion of IR and IRS1 and sensitization of signaling via the
IR in vitro and in the mutant mice. These data argue blasts deficient in EGFR or in Src kinases.
There is also good evidence for coupling between EGFRthat PTP1B is an important negative regulator of IR (El-
chebly et al., 1999). signaling and the signaling pathway activated by trans-
forming growth factor-b (TGFb) receptors. The TGFb fam-Receptor Endocytosis and Degradation
Growth factor stimulation results in rapid endocytosis ily of cytokines mediate their biological responses by
binding to and activating a hetero-tetrameric complexand degradation of both the receptor and the ligand.
Ligand binding induces receptor clustering in coated composed of receptors with Ser/Thr activity designated
TGFb receptor-I and -II (Massague et al., 2000 [this issuepits on the cell surface, followed by endocytosis, migra-
tion to multivesicular bodies and eventual degradation of Cell]). Stimulation of TGFb receptors results in the
phosphorylation of Smad proteins, followed by theirby lysosomal enzymes. It has been shown that degrada-
tion of EGFR is dependent on protein tyrosine kinase translocation to the cell nucleus and consequent en-
hancement of transcriptional activity of target genes.activity and that a kinase-negative receptor mutant recy-
cles to the cell surface for reutilization (Ullrich and EGF exerts an inhibitory response on TGFb signaling, by
inducing phosphorylation of Smad proteins at specificSchlessinger, 1990). The rapid endocytosis and degra-
dation of activated EGFR and other RTKs attenuates sites that prevent nuclear translocation and cause an
inhibition of transcriptional activity (Kretzschmar et al.,the signal generated at the cell surface in response to
growth factor stimulation. Recent studies suggest that 1997; de Caestecker et al., 1998; Zhang et al., 1998b).
It is already apparent that signaling pathways do notthe oncogenic protein Cbl plays a role in regulating
EGFR and PDGFR degradation. Cbl contains several function in isolation, and cannot be presented or consid-
ered in a simple linear fashion as would be proposedsubdomains, including an SH2-like domain that is re-
sponsible for binding to activated RTKs, and a RING by genetic analyses. A more realistic picture is that sig-
naling pathways are linked together in a large proteinfinger domain that functions as a ubiquitin ligase. Bind-
ing of EGFR or PDGFR to Cbl leads to ubiquitination of network that is subjected to multiple stimulatory and
inhibitory inputs, as well as complex feedback mecha-the receptor and subsequent degradation by the proteo-
some (Joazeiro et al., 1999) (Figure 5B). On the other nisms. Such complexity is essential for mediating the
pleiotropic responses of growth factors in developmenthand, complex formation with activated receptors re-
sults in tyrosine phosphorylation of Cbl followed by re- and in the adult animal.
cruitment to it of signaling proteins such as PI-3 kinase,
arguing that Cbl may also function as a docking protein Factors that Determine the Specificity
for recruitment of effector proteins. of Signaling Pathways
A major unanswered question in the field of signal trans-
duction concerns the origin of signal specificity. How areCoupling with Heterologous Signaling Pathways
In recent years it has become apparent that RTKs and the myriad of extracellular cues transmitted to induce
specific biological responses? It is not at all clear howthe signaling pathways they activate are part of a large
signaling network that can be regulated by multiple ex- activation of a given RTK at the cell membrane by a
specific ligand could utilize the currently known reper-tracellular cues such as cell adhesion, agonists of G
protein–coupled receptors, lymphokines or stress sig- toire of intracellular signaling pathways to transduce a
unique biological response. Insulin and NGF, for in-nals (Carpenter, 1999). It has also been shown that cell
adhesion via integrin receptors leads to activation of stance, stimulate unique biological responses in their
target tissues. Yet, the intracellular signaling pathwaysseveral RTKs including the receptors for insulin, EGF,
PDGF, and FGF resulting in tyrosine phosphorylation of that are activated by insulin, NGF, or other growth fac-
tors are very similar indeed. In other instances, activa-target proteins and activation of signaling pathways that
are normally activated by these receptors. It has been tion of the same signaling molecules in different cells
leads to distinct responses. Why, for example, doesproposed that receptor activation induced by cell adhe-
sion is mediated by coclustering of integrins with RTKs, stimulation of PI-3 kinase by insulin in muscle cells result
in enhancement of metabolic processes, while stimula-although the precise mechanism of complex formation
between integrins and RTKs is not understood. tion of PI-3 kinase by NGF in neuronal cells leads to an
antiapoptotic signal? Moreover, what are the factorsRTKs have also been shown to be activated by mem-
brane depolarization, by various stress responses includ- that determine the biological outcome of a signal gener-
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ated by a given receptor tyrosine kinase in different are involved in cell signaling are concentrated in choles-
terol-rich microdomains designated “membrane rafts”cellular context? Why does stimulation of an RTK (e.g.,
TrkA, FGFR, Ret) in fibroblasts result in cell proliferation (Simons and Ikonen, 1997). It is thought that “membrane
rafts” function as sites of assembly of proteins involvedwhereas stimulation of the same RTK in neuronal cells
results in cell differentiation? Several mechanisms have in cell signaling including cell surface receptors, GPI-
liked proteins, Src kinases, and Ras proteins (Brownbeen proposed for the control of specificity in cell sig-
naling. and London, 2000). However, it is not clear yet whether
membrane rafts exist in the context of living cells (Edidin,Combinatorial Control
Signal specificity may be defined in part by a combinato- 1997) or whether this phenomenon represents an artifact
caused by detergent solubilization.rial control. Every RTK recruits and activates a unique
set of signaling proteins via its own tyrosine autophos- The translocation of STAT proteins from the cell mem-
brane into the nucleus is another example for the rolephorylation sites and by means of the tyrosine phos-
phorylation sites on closely associated docking proteins of protein localization in cell signaling (Darnell et al.,
1994; Ihle, 1995). Initially, STAT proteins are bound to(e.g., Gab1, FRS2). The combinatorial recruitment of a
particular complement of signaling proteins from a com- the cytoplasmic domains of lymphokine receptors in
proximity to protein tyrosine kinases of the JAK family.mon preexisting pool of signaling cassettes is one mech-
anism for control of signal specificity. This process is Stimulation of lymphokine receptor or RTKs leads to
tyrosine phosphorylation of STAT resulting in homotypicfurther regulated by differential recruitment of stimula-
tory and inhibitory proteins by the different receptors or heterotypic dimerization followed by nuclear translo-
cation and regulation of transcription of target genes.and downstream effector proteins leading to fine tuning
of cellular responses. Signal Duration and Amplitude
Cellular signaling pathways could be considered asThe Role of Scaffold Proteins
It has been shown that scaffolding proteins that bind components of intracellular circuits that are generated
by protein networks. According to this view, signal trans-simultaneously to several proteins are able to insulate
key components of signaling pathways from closely re- mission and biological outcome should be affected by
quantitative considerations such as signal duration andlated signaling cascades (Whitmarsh and Davis, 1998).
In yeast, the scaffolding protein Ste5 has been shown signal strength (Marshall, 1995). For instance, RTKs that
induce transient stimulation of MAPK (e.g., EGFR, IR)to interact with a pheromone-activated G protein and
with components of MAP kinase cascade. Ste5 forms stimulate PC12 cell proliferation while RTKs that stimu-
late a sustained and robust MAPK response (e.g., NGFR,a complex with Ste11, Ste7, and Fus3P leading to insula-
tion of pheromone-induced MAP kinase cascade from FGFR) promote neuronal differentiation of the same
cells. In fact, overexpression of IR or EGFR in PC12closely related signaling pathways. Another example is
JIB, a protein that functions as a scaffolding protein in cells leads to sustained MAPK response resulting in
cell differentiation, although the same receptors give athe JNK signaling cascade in mammalian cells (Davis,
2000). There is also evidence that particular members proliferative response when expressed at lower levels.
These experiments shows that biological outcome (pro-of the MAPK cascade form a complex with a specific
upstream activating kinase and downstream effector- liferation versus differentiation) is determined by quanti-
tative modulation of signal threshold (Marshall, 1995).kinase to provide insulation from other MAP kinase cas-
cades (Kallunki et al., 1994). It remains to be determined Signal threshold can be determined by the specific activ-
ity of a given RTK, and by the balanced action of thewhether RTKs induce specific biological responses by
utilizing specific scaffold proteins. various inhibitory or stimulatory signals that are acti-
vated by the RTK. For example, the signal generated byCellular Compartmentalization
In recent years it has become apparent that the cellular an RTK can be prolonged by generation of hydrogen
peroxide that blocks inhibitory protein tyrosine phos-localization of proteins involved in cell signaling has a
profound impact on their biological activity. As many of phatases or by phosphorylation of docking proteins that
promote signal amplification by recruiting of multiplethe targets of RTKs are located at the cell membrane,
membrane translocation is required for activation of many signaling molecules. Signaling pathways are also sub-
jected to multiple negative feedback mechanisms at thecellular processes. Binding of SH2, PTB, or SH3 do-
mains to activated receptors or to membrane-linked level of the receptor itself by inhibitory protein tyrosine
phosphatases and by receptor endocytosis and degra-docking proteins leads to membrane translocation. In
addition, membrane translocation is regulated in part dation. In addition, the specific activity of key effector
proteins can be negatively regulated by inhibitory sig-by PH or FYVE domains, two protein modules that bind
to different phosphoinositides. It has been shown that nals. For example, MAPK responses are inhibited by
protein phosphatases that dephosphorylate and inacti-binding of proteins containing PDZ domains to their
canonical target sequences at the C termini of signaling vate this enzyme. The two phosphoinositide phospha-
tases PTEN and SHIP dephosphorylate specifically theproteins will induce the assembly of specific sets of
signaling proteins in specific regions at the inner face 39 or 59 phosphate of the PtdIns(3,4,5)P3 inositol ring,
respectively, leading to inhibition of cellular responsesof the cell membrane. Protein assembly at the cell mem-
brane, mediated by multi-PDZ domain containing pro- mediated by PI-3 kinase products. The balance between
the various stimulatory and inhibitory responses will ulti-teins, may facilitate the phosphorylation of specific sub-
strates by a kinase that is part of the same complex or mately determine the strength and duration of the sig-
nals that are transmitted through the networks of signal-activation of a GTPase by an exchange factor that is
located at the same assembly. ing cascades following their initiation at the cell surface
in response to RTK stimulation.It has been proposed that a variety of proteins that
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Cellular Context shared by multiple signaling cascades. Consequently,
more sophisticated tools should be developed and ap-The biological outcome of signals generated at the cell
surface in response to RTK stimulation is strongly de- plied for the analysis of cellular signaling pathways.
There is need for new techniques for determination ofpendent on cellular context. The same RTK will induce
a totally different response when expressed in different protein localization (Teruel and Meyer, 2000 [this issue
of Cell]) and measurement of kinetics of cellular reac-cells or at different stages of differentiation of a particu-
lar cell lineage (Sahni et al., 1999). For instance, in early tions in the context of living cells and even in the live
animal. In addition, detailed analyses of gene expressiondevelopment, FGFR1 plays an important role in control
of cell migration, a process crucial for mesodermal pat- patterns by microarray analysis of genes that are ex-
pressed in response to growth factor stimulation (Fam-terning and gastrulation. Stimulation of FGFR1 in fibro-
blasts on the other hand, leads to cell proliferation while brough et al., 1999) of cells derived from normal or
pathological tissues will reveal new links between sig-stimulation of FGFR1 expressed in neuronal cells in-
duces cell survival and differentiation. The most plausi- naling pathways. Finally, the modern biochemist and
geneticists will have to adopt approaches that haveble explanation for these observations is that different
cells express cell type–specific effector proteins and been developed by engineers to describe complicated
networks (e.g., system analysis) in order to obtain atranscription factors that mediate the different re-
sponses. According to this view, RTKs and their signal- coherent and realistic perspective on cell signaling (Lev-
chenko et al., 2000; Jordan et al., 2000 [this issue ofing pathways are capable of feeding into multiple pro-
cesses thus regulating the activity of different effector Cell]).
proteins and transcriptional factors in different cellular
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